BOLDEN African News · Thursday 12 November 2026
Swedfund funds feasibility studies for Apifa Biotech's planned biopharma park at Konza Technopolis
Swedfund, Sweden's development finance institution, is giving grant funding for preparatory studies on a Biopharma Life Sciences Park at Konza Technopolis, developed by Apifa Biotech in partnership with the Konza Technopolis Development Authority. A consortium of JLL and IQVIA will carry out the feasibility study. The project, valued at KSh 27.8 billion (US$216 million), was approved by the National Treasury in April 2026 to move into its development phase.
Why it matters
Kenya aims to make at least half of its essential health products locally, and this is one of the first large projects meant to cut the country's reliance on imported medicines.
Sources: TV47, HealthCare Middle East & Africa · 14 November 2026
